
Chemical and Pharmaceutical Bulletin p. 452 - 457 (1998)
Update date:2022-08-04
Topics:
Tsuda, Yuko
Wanaka, Keiko
Tada, Mayako
Okamoto, Shosuke
Hijikata-Okunomiya, Akiko
Okada, Yoshio
The synthetic plasma kallikrein (PK) inhibitor trans-4- aminomethylcyclohexanecarbonylphenylalanine-4-carboxymethylanilide (PKSI- 527) consists of three parts. Each part was replaced by analogues in an attempt to improve the potency and the selectivity of PKSI-527. Among the peptides examined, trans-4-aminomethyl-cyclohexanecarbonylphenylalanine-4- carboxyanilide (peptide 16) inhibited PK with a high selectivity and an IC50 value of 2.7 μM, being as potent as PKSI-527.
View MoreShanghai ZaiQi Bio-Tech Co., Ltd.,
Contact:+86-21-5482 4098
Address:Bldg. No.7, No.201 MinYi Rd,Songjiang CaoHeJing High-Tech Park Shanghai 201516 P,R,China
Tianjin Emulsion Science&Technology Development Co.,Ltd
Contact:13901380442
Address:Vake Garden New Town New Yi Bai Road Beichen District Tianjin,China
Contact:0792-8228321
Address:10TH Floor No.121 binjiang Road Xunyang District
Wuxi Innopal International Trade CO.,LTD
Contact:+86-510-80711901-8003
Address:Room 402,Building 5,Longze Garden,No.17,South huanjiu Road,Yixing City, Jiangsu,China
Shanghai SMEC Trading Co., Ltd.
website:http://www.shanghaismec.com
Contact:+86-21-68811293
Address:ROOM 1101,NO.800 SHANGCHENG RD,SHANGHAI,CHINA
Doi:10.1246/bcsj.34.1846
(1961)Doi:10.1002/jhet.5570350235
(1998)Doi:10.1134/S1070363219040169
(2019)Doi:10.1021/jo9803434
(1998)Doi:10.1016/S0040-4039(01)00101-0
(2001)Doi:10.1021/ja01340a054
(1932)